Pili have been shown to contribute to the virulence of different Gram-positive pathogenic species. Among other critical steps of bacterial pathogenesis, these structures participate in adherence to host cells, colonization and systemic virulence. Recently, the presence of at least four discrete gene clusters encoding putative pili has been revealed in the major swine pathogen and emerging zoonotic agent Streptococcus suis. However, pili production by this species has not yet been demonstrated. In this study, we investigated the functionality of one of these pili clusters, known as the srtF pilus cluster, by the construction of mutant strains for each of the four genes of the cluster as well as by the generation of antibodies against the putative pilin subunits. Results revealed that the S. suis serotype 2 strain P1/7, as well as several other highly virulent invasive S. suis serotype 2 isolates express pili from this cluster. However, in most cases tested, and as a result of nonsense mutations at the 5′ end of the gene encoding the minor pilin subunit (a putative adhesin), pili were formed by the major pilin subunit only. We then evaluated the role these pili play in S. suis virulence. Abolishment of the expression of srtF cluster-encoded pili did not result in impaired interactions of S. suis with porcine brain microvascular endothelial cells. Furthermore, non-piliated mutants were as virulent as the wild type strain when evaluated in a murine model of S. suis sepsis. Our results show that srtF cluster-encoded, S. suis pili are atypical compared to other Gram-positive pili. In addition, since the highly virulent strains under investigation are unlikely to produce other pili, our results suggest that pili might be dispensable for critical steps of the S. suis pathogenesis of infection.
Citation: Fittipaldi N, Takamatsu D, Domínguez-Punaro MdlC, Lecours M-P, Montpetit D, Osaki M, et al. (2010) Mutations in the Gene Encoding the Ancillary Pilin Subunit of the Streptococcus suis srtF Cluster Result in Pili Formed by the Major Subunit Only. PLoS ONE 5(1): e8426. doi:10.1371/journal.pone.0008426
Editor: Frank R. DeLeo, National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States of America
Received: October 5, 2009; Accepted: December 1, 2009; Published: January 5, 2010
Copyright: © 2010 Fittipaldi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) through grants to MG (#154280 and Discovery Accelerator Supplement #380299) and by the Japan Society for the Promotion of Science (JSPS) through a grant to TS. NF, MCDP and MPL are the holders of NSERC postgraduate scholarships. NF is the recipient of a JSPS Summer Program fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Streptococcus suis is a major swine pathogen responsible for severe economic losses to the porcine industry . This bacterium is also a zoonotic agent affecting, for the most part, people in close contact with swine or pork by-products . In recent times, however, S. suis has strongly emerged as an important public health issue in South East and East Asia. For instance, it has been shown that this pathogen is the primary cause of adult meningitis in Vietnam  and the second in Thailand . Moreover, in 2005, more than 200 human S. suis cases with a death toll of 39 were reported during a single outbreak in China . In both swine and humans the main clinical manifestations of S. suis are meningitis and septicemia , . Most cases of S. suis disease are caused by strains belonging to the serotype 2 and, therefore, almost all studies on virulence factors and pathogenesis of the infection have been carried out with this serotype . It has been shown that the polysaccharide capsule is essential for the virulence of S. suis by allowing the bacterium to escape phagocyte killing . Modifications of cell wall components such as the N-deacetylation of the peptidoglycan and the D-alanylation of lipoteichoic acids have recently been shown to contribute to the virulence of S. suis , . As well, an isogenic mutant for a serum opacity-like factor has been found to be attenuated in pigs . In contrast, other factors, such as a hemolysin (suilysin), the so-called extracellular protein factor (EF) and a muramidase-released protein (MRP), have been shown to be linked to, but not essential for, the virulence of S. suis .
S. suis needs to invade the central nervous system (CNS) in order to cause meningitis in swine. It has been proposed that, among other routes, this pathogen might reach the CNS by crossing the porcine blood-cerebrospinal fluid barrier as well as the blood-brain barrier by transcytosis through porcine choroid plexus epithelial cells and brain microvascular endothelial cells (BMEC), respectively , , . In previous work using an in vitro model of S. suis-porcine BMEC interactions and the selective capture of transcribed sequences (SCOTS), several genes were identified which were highly upregulated by this bacterium upon contact with these host cells . One of these genes was SSU_0424 encoding a putative signal peptidase  (the nomenclature used is that of the Sanger Institute for the very recently finished sequencing project of strain P1/7 ). Further in silico analysis showed that the three genes downstream the signal peptidase identified by SCOTS, namely SSU_0426, SSU_0427 and SSU_0428, putatively encode two cell wall sorting signal (CWSS)-containing proteins and a class C sortase, respectively , . This genetic organization is similar to that of some described Gram positive pilus cluster , . In a recent study, the sortase gene was renamed as srtF and the signal peptidase gene as sipF (for signal peptidase gene in the srtF cluster) . The genes encoding the two CWSS-containing proteins were renamed as sfp2 and sfp1 (for srtF-associated pilin subunit), respectively ; sfp2 has been suggested to encode the putative pilin ancillary subunit (a putative adhesin) and sfp1 the putative main pilin subunit forming the pilus backbone . The full cluster was named srtF pilus cluster  and found to be highly homologous to the Streptococcus agalactiae (Group B Streptococcus, GBS) pilus island 2b .
Gram-positive pili participate in biofilm formation , ,  and have been shown to play important roles in other aspects of the virulence of several invasive human streptococcal pathogens, including GBS, Streptococcus pneumoniae and Streptococcus pyogenes (Group A Streptococcus, GAS) . For instance, at least two pneumococcal pili are involved in adherence to epithelial cells and contribute to the virulence of these organisms , , . In GBS and GAS, besides contributing to phagocyte resistance and systemic survival , pili participate in adhesion to extracellular matrix proteins  and to human epithelial cells . Furthermore, pili have been shown to be important for GBS adherence to and invasion of human BMEC . We therefore speculated that putative pili encoded by the srtF cluster might play a role during the interactions of S. suis with porcine BMEC and, also, that they might contribute to the virulence traits of this pathogen. In this work, we characterized the srtF pilus cluster in a highly virulent field strain of S. suis serotype 2 and investigated the role that pili encoded by this cluster play in some aspects of the pathogenesis of the S. suis infection.
The srtF Pilus Cluster Encodes Pili Formed by the Major Pilin Subunit Only
The genome of the virulent field strain P1/7 contains a genetic region designated as the srtF pilus cluster where four genes encoding a putative signal peptidase (sipF), putative ancillary and major pilin subunits (sfp2 and sfp1, respectively) and a putative dedicated class C sortase (srtF) are found , ,  (Figure 1). To assess whether the srtF cluster mediates formation of pili in S. suis, we inactivated each of the four genes by precise, in frame, allelic replacement. The resulting mutant strains exhibited growth kinetics equivalent to those of the WT parent strain upon cultivation in standard laboratory media and other media used in our in vitro assays (data not shown). At first, pili production by the WT and mutant strains was studied by Western-blotting of cell wall protein extracts (mutanolysin digests) using a specific antiserum directed against the putative pilin subunit Sfp1. In the WT sample, this antiserum recognized a band of approximately 37 kDa that likely corresponds to a Sfp1 monomer whose N-terminal signal peptide and C-terminal residues after the CWSS motif have been removed (predicted MW of 51 kDa for a native unprocessed monomer). As well, high molecular weight species that likely represent Sfp1-containing polymers were detected in the WT sample (Figure 2, lane 1). The monomer and polymers were also detected in the ΔsipF and Δsfp2 mutants (lanes 2 and 3), although the intensity of the higher molecular weight polymers was lower in the former mutant. By contrast, neither monomer nor polymers were detected in the Δsfp1 mutant (lane 4). On the other hand, the Sfp1 monomer, but not polymerized structures were detected in the cell wall extracts of the ΔsrtF mutant (lane 5), indicating that polymerization of pili requires the action of the dedicated class C sortase SrtF.
(Available at the Sanger Institute, http://www.sanger.ac.uk/Projects/S_suis/). The srtF pilus cluster comprises 4 genes: sipF encoding a signal peptidase; sfp2, which is now considered to be a pseudogene formed by the previously reported coding sequences SSU_0425 and SSU_0426 (indicated by the thick dark grey arrows); sfp1, encoding the major pilin subunit; and srtF, encoding a dedicated (pilin polymerase) sortase. Small arrows indicate the annealing positions of the primers used to generate the 6xHis recombinant proteins rSfp1, rSfp2A and rSfp2B. The dashed lines surrounded by arrows indicate the regions deleted in the ΔsipF, Δsfp2, Δsfp1 and ΔsrtF mutants.
Mutanolysin-extracted surface proteins were resolved on Tris-HCl Ready gradient 4–15% SDS-PAGE gels (BioRad) and transferred onto nitrocellulose membranes. Sfp1 was detected using specific rabbit antisera and horseradish peroxidase-coupled, goat anti-rabbit secondary antibodies (Jackson ImmunoResearch, West Grove, PA). Five µg of protein were loaded per well. M: Molecular weight markers. Lane 1: WT strain P1/7. Lane 2: ΔsipF mutant. Lane 3: Δsfp2 mutant. Lane 4: Δsfp1 mutant. Lane 5: ΔsrtF mutant. See the results section for more details.
We then performed Western-blotting using two different antisera raised against two different fragments of Sfp2 (named rSfp2 A and B, respectively). Sfp2 is, based on homology to GBS PI-2A (37% of positives, 29% of identity to SAN_1519 of GBS COH1), the putative minor pilin subunit of the srtF cluster , . Despite the fact that both recombinant proteins were recognized by the respective antisera (Figure 3A, B and C, lanes 1), we failed to detect any reactive protein in both whole cell and cell wall protein preparations, as well as in concentrated culture supernatant preparations of the WT (Figure 3A, B and C, lanes 2) and mutant strains (data not shown). Although these results were at first surprising, while this manuscript was in preparation the genome of strain P1/7 was published . In the released data the gene reported here as sfp2 (SSU_0426) and a short open reading frame (SSU_0425) upstream of sfp2 are now annotated as a single pseudogene SSU_0425 , . In this pseudogene a premature ochre nonsense mutation is found after codon 49 (Figure 1). Therefore, failure of our two anti-Sfp2 antisera to recognize the native Sfp2 protein confirms this new released sequence data for strain P 1/7.
Western-blotting analysis of A) whole cell protein preparations, B) mutanolysin-extracted surface protein preparations and C), 10-fold concentrated culture supernatant preparations of S. suis strain P1/7 and other highly invasive serotype 2 isolates with two different rabbit antisera recognizing two different recombinant 6xHis-tagged fragments of Sfp2 (rSfp2A: upper panel; rSfp2B, middle panel). Proteins were resolved on 7.5% SDS-PAGE gels and transferred onto nitrocellulose membranes. Horseradish peroxidase-coupled, goat anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA) were used as secondary antibodies. Although the recombinant 6xHis-Sfp2 fragments were recognized by the respective antisera (lanes 1), no signal corresponding to the native protein was detected in any of the tested strains. To assess the quality of the protein preparations used, detection of the known LPXTG-containing protein Sao ,  was carried with an anti-Sao pAb. This protein, for which MW variants have been described, was detected in all the tested strains and fractions (lower panel). The same amount of total protein was loaded per well for each fraction. M: Molecular weight markers. Lane 1: recombinant 6xHis-Sfp2 fragments. Lane 2: Strain P1/7. Lane 3: Strain 31533. Lane 4: Strain 166. Lane 5: Strain D24. Lane 6: Strain S735 (serotype 2 reference strain). Lane 7: Strain D282. Lane 8: Strain LEF95. Lane 9: Strain HUD Limoges. Lane 10: strain 89–1591.
Electron Microscopy Evidence for Pilus-Like Structures
Antisera raised against recombinant pilin proteins were also used to investigate the protein localization in the cell surface of strain P 1/7 and selected mutants by immunogold electron microscopy (IEM). As expected from the previous Western-blotting results, labeling was not observed with antibodies directed against Sfp2 (data not shown). On the other hand, confirming Western-blotting results, immunogold labeling with the antiserum specific for Sfp1 revealed long and abundant pilus-like structures extending up to 800 nm from the bacterial surface in the WT strain (Figure 4, left panel). Suggesting that Sfp1 monomers form the backbone of the pilus, pili were entirely decorated by the anti Sfp1-specific antiserum and 10 nm colloidal gold-conjugated anti-rabbit IgG antibodies. As expected, no labeling was observed for the Δsfp1 mutant (Figure 4, center panel), while labeling of the bacterial surface but not pilus-like structures was observed for the ΔsrtF mutant (Figure 4, right panel). No immunogold labeling was observed using control rabbit normal antisera (data not shown).
In the WT strain P1/7 (left) immunogold labeling showed the presence of thin pilus-like structures that were entirely decorated by the anti Sfp1-specific antiserum and 10 nm colloidal gold-conjugated anti-rabbit IgG antibodies. In contrast, no labeling was detected in the Δsfp1 mutant (center) while the ΔsrtF mutant (right) presented labeling of the bacterial surface but not pilus-like appendages. Magnification: 60,000×.
Evaluation of the Role of the Housekeeping Sortase SrtA in Pili Production
The housekeeping sortase SrtA has been shown to mediate anchoring of LPXTG proteins to the S. suis cell wall peptidoglycan . We hypothesized that if SrtA was required for the attachment of pili into the cell wall peptidoglycan, then pili produced by a ΔsrtA mutant should be released into the media in higher amounts than those produced by the WT strain. To investigate the validity of this hypothesis, we constructed a ΔsrtA mutant by allelic exchange. When we tested production of Sfp1 polymers in the ΔsrtA mutant by Western-blotting of cell wall proteins, the amount of Sfp1 polymers detected by our antiserum in the ΔsrtA mutant was similar to that found in the WT strain. This result is in agreement with a previous report describing the contribution of SrtA to pili production in GBS  and conceivably explained by the fact that the pili subunits are assembled by the pilin polymerase SrtF irrespective of the presence of SrtA, remaining transiently associated to the cell wall. However, in contrast to the WT strain, no Sfp1 monomers could be detected in the cell wall fraction of the ΔsrtA mutant (Figure 5A, lanes 1 and 2). The WT phenotype was restored by complementation in trans of the ΔsrtA mutant (Figure 5A, lane 4). As expected, more Sfp1 monomers were detected in the culture supernatant of the ΔsrtA mutant in comparison to the WT strain or the complemented ΔsrtA mutant. In addition, the amount of Sfp1 polymers released in the culture supernatant fraction by the ΔsrtA mutant was slightly higher than that of the WT strain or the complemented mutant (Figure 5A). We then analyzed pili production by the ΔsrtA mutant using IEM. Figure 5B shows a representative ΔsrtA mutant bacterial cell presenting pilus-like structures much longer than those found in the WT strain, a result that suggests that SrtA might be involved in termination of pilus assembly. Interestingly, and in contrast to the WT strain, pili produced by the ΔsrtA mutant were scarce in the bacterial surface. Indeed, most cells presented one of these structures and many of them were devoid of pili. Together with the Western-blotting experiments, these IEM results demonstrate that the housekeeping sortase SrtA is not necessary for pilus polymerization but strongly suggest that it is required for anchoring the pilus to the cell wall.
A) Western-blotting analysis using anti-Sfp1 antisera of cell wall-anchored proteins (left) and concentrated culture supernatants (right) of S. suis strain P1/7 (lane 1), its derived ΔsrtA mutant (lane 2), a mock-complemented ΔsrtA mutant (lane 3) and the ΔsrtA mutant complemented in trans with srtA (lane 4) (upper panel). SDS-PAGE and Western-blotting were performed as described in Figure 2 legend. While Sfp1 polymers were detected in the cell wall fraction of all four tested strains, Sfp1 monomers were absent from the ΔsrtA mutant and the mock-complemented ΔsrtA. Reintroduction of the srtA gene into the ΔsrtA mutant complemented the defect (left upper panel). More Sfp1 monomers and slightly more Sfp1 polymers were detected in the culture supernatant of the ΔsrtA mutant, while the WT phenotype was restored by complementation with the srtA gene (right upper panel). To ensure that equal amounts of protein were loaded per well in the supernatant fraction, detection of the previously reported  secreted protein extracellular factor (EF) was carried out using the same samples and a previously described monoclonal antibody  (lower panel). M: Molecular weight markers. B) Immunogold labeling and transmission electron microscopy (magnification: 20,000×) showing scarce but very long pilus-like structures on the cell surface of the ΔsrtA mutant. Note the differences in magnification with the microphotographs shown in Figure 4.
Production of Pili by the srtF Cluster in Other Virulent S. suis Strains
Absence of the minor subunit in polymerized pili of strain P1/7 seems to be the consequence of a genetic conversion which resulted in inactivation of sfp2 in this strain. Other strains might, however, present an intact sfp2 gene. Indeed, by the use of PCR amplification with specific primers a previous study demonstrated the presence of the srtF pilus cluster genes in several isolates of S. suis serotype 2 from various sources . We therefore analyzed whether the S. suis serotype 2 reference strain and other well-characterized highly virulent field strains (Table 1) can express pili that are formed by both Sfp1 and Sfp2 subunits. Western-blotting results showed that most of the investigated strains produced pili formed by the major pilin subunit Sfp1 only and were devoid of Sfp2 (Figures 3A, B and C, lanes 3 to 10 and Figure 6). The exception was strain 89–1591, for which we failed to detect not only Sfp2 but also Sfp1 monomers (Figure 6, lane 9), despite the fact that it has been reported that this strain contains all four srtF cluster genes . However, further analysis of sequence data for this particular strain (available at http://genome.jgi-psf.org/draft_microbes/strsu/strsu.home.html) showed that these four genes are not organized in a typical pilus cluster but, instead, they are found at different locations in the genome (data not shown). Consistently, we failed to amplify the srtF pilus cluster in this strain using the primer pair PSF-ID1 and srtF-ID8 (Table S1), which anneal to the region upstream of sipF and downstream of srtF, respectively, while a fragment of approximately 9.4 kb was amplified from P1/7 and the remaining strains (Fig. S1).
SDS-PAGE of mutanolysin extracted surface proteins and Western-blotting were performed as described in Figure 2 legend. Five µg of protein were loaded per well. M: MW markers. Lane 1: Strain P1/7. Lane 2: Strain 31533. Lane 3: Strain 166. Lane 4: Strain D24. Lane 5: Strain S735 (serotype 2 reference strain). Lane 6: Strain D282. Lane 7: Strain LEF95. Lane 8: Strain HUD Limoges. Lane 9: Strain 89–1591. See the results section for more details.
As mentioned above, Sfp2 could neither be detected in extracts of whole cell or cell wall proteins, nor in concentrated culture supernatant fractions of the additional strains under investigation. Consistently, when we sequenced the srtF cluster in these strains, the same ochre nonsense mutation found in strain P1/7 was detected in the sfp2 gene (GenBank Accession numbers GQ279101 to GQ279107).
The srtF Pilus is Dispensable for Adhesion to and Invasion of Porcine BMEC
The first gene of the srtF pilus cluster, sipF, has been found to be highly upregulated by S. suis upon contact with cultured porcine BMEC, which are a major type of cells forming the BBB . GBS pili have been shown to be important for adhesion of that pathogen to human BMEC, although in GBS adhesion required the presence of the ancillary subunit . Despite the fact that the homologous putative adhesin Sfp2 is missing from S. suis pili encoded by the srtF cluster, we investigated the contribution of these pili to the adherence to and invasion of porcine BMEC using in vitro assays. As expected for an adhesin-less pilus, Figure 7A shows that there were no significant differences between the WT and mutant strains regarding S. suis adherence to porcine BMEC. A similar absence of differences between the WT and mutant strains was observed when invasion of porcine BMEC by the WT and mutant strains was evaluated (Figure 7B). In contrast, a ΔsrtA mutant was severely impaired in its interactions with porcine BMEC, as previously reported .
The mutants showed similar levels of adherence to (A) and invasion of (B) porcine BMEC. Data for the WT strain (adherence = 1.59×105±1.42×104 recovered CFU/well; invasion = 1.79×103±1.54×102 recovered CFU/well) have been normalized to 100%. Data are from at least 4 independent experiments. Error bars show the standard error of the mean. No significant differences were found between the WT and the srtF cluster mutant strains, while the ΔsrtA mutant, used as an internal control, showed significant differences in both adherence and invasion (t-test, P<0.05, indicated by the asterisk).
Abolishment of Pili Production Does Not Impair S. suis Sepsis in the Mouse
Using a GBS mutant that produces adhesin-less pili, it has been shown that the pilus backbone itself promotes phagocyte resistance and systemic virulence . On the basis of these data, we hypothesized that the adhesin-less srtF pilus cluster described here might contribute to S. suis sepsis. To assess this hypothesis, we performed in vivo trials using a validated CD1 mouse model of S. suis infection that uses the intraperitoneal route of inoculation . In a first experiment, mice received 5×107 CFU of the WT or mutant strains. Most mice in the WT and the mutant groups presented severe clinical signs associated with septicemia, such as depression, swollen eyes, weakness and prostration during the first 24 h post-inoculation (pi). Most mice died from septicemia in all groups during the first 2 days of the trial and the remaining animals were killed for ethical reasons at day 3 pi (Figure 8A). Moreover, S. suis could be isolated at high titers (>1×107 CFU/ml) from blood samples and organs such as the liver and spleen of septicemic animals in all the groups (>1×107 CFU/0.5 g of tissue in some animals) (data not shown). These results suggest that pili encoded by the srtF pilus cluster are not major mediators of S. suis sepsis. However, the high dose of inoculation used may not allow for discerning more modest contributions of the pilus structures to the virulence of this pathogen. To address this concern, we performed a second in vivo trial using a lower dose of inoculation (1×107 CFU). At this lower dose, animals in the WT and the mutant groups showed, overall, less severe clinical signs than in the previous experiment conducted with the higher dose. Moreover, death was delayed and strongly reduced and several animals in all the groups survived the trial. However, as in the previous trial, no significant differences in the severity of the clinical signs, bacterial isolation from blood and organs (data not shown), nor in mortality (LogRank test, p = 0.388) (Figure 8B), were observed between the WT and mutant groups. Taken together, the in vivo trial results strongly argue that pili encoded by the srtF cluster may be dispensable for S. suis sepsis.
The presence of thin pilus-like structures on the surface of S. suis was noticed as early as 1990 by ultrastructural studies using electron microscopy . However, only very recently Fittipaldi et al. identified a first pilus cluster in S. suis, later renamed by Takamatsu et al. as the srtF pilus cluster , . Results presented here show that in the highly virulent S. suis strain P1/7 and in other well characterized virulent serotype 2 strains the srtF pilus cluster encode pili which are formed by the major pilin subunit Sfp1 only. Indeed, Western-blotting of S. suis cell wall proteins with antibodies directed against the Sfp1 subunit clearly showed, for these WT strains, the presence of polymers of the Sfp1 pilin subunit, compatible with a pilus structure in which Sfp1 constitutes the backbone. Moreover, IEM results for strain P 1/7 showed that the gold particles were localized on the S. suis surface in pilus-like appendages. Consistently, these structures were absent from a Δsfp1 mutant.
It has been shown that in Gram-positive bacteria polymerization of pili is driven by specific, dedicated sortases encoded by genes that are clustered together with the genes encoding the pilin subunits they polymerize, while attachment to the cell wall peptidoglycan is mediated by the housekeeping sortase , . In agreement, our results demonstrate that SrtF drives the polymerization of the pilus encoded by the S. suis srtF cluster. In fact, Sfp1 monomers, but not Sfp1 polymers, were detected on the cell wall of the corresponding ΔsrtF mutant. These monomers are likely to be attached to the peptidoglycan through the action of SrtA, as suggested by the fact that they are absent from the cell wall fraction but more abundant in the culture supernatant of the corresponding ΔsrtA mutant. In this latter mutant, in agreement with the proposed transient, non-covalent anchoring of pili to the cell wall by the dedicated sortases in a housekeeping sortase-less genomic background , , , , polymerized pili could be observed in the cell wall fraction. However, Sfp1 polymers were released in higher amounts to the culture supernatant by the ΔsrtA mutant in comparison to the WT strain. Moreover, pili produced by the ΔsrtA mutant were, in average, much longer than those observed in the WT parent strain. This observation might imply a role for the housekeeping sortase SrtA in termination of the chain. Additional experiments are needed to ascertain this hypothesis.
To our knowledge, the role in pili biogenesis of signal peptidase-like enzymes found in pilus clusters has only been investigated for the GAS T3 and the S. pneumoniae PI-2 pili , , . It was observed that these signal peptidases (named SipA in the former two species) were essential for pili polymerization and assembly , , . However, inactivation of the S. suis sipF gene did not prevent the polymerization of the pilin backbone subunit Sfp1. It has been suggested that GAS SipA is unlikely to function as a signal peptidase, since it lacks the highly conserved and catalytically important serine and lysine residues of these enzymes . Instead, a putative chaperone function for GAS SipA has been proposed . In contrast, S. suis SipF does possess these two conserved residues (data not shown). Therefore, it might be hypothesized that S. suis SipF may function as a signal peptidase involved in the removal of the Sfp1 signal peptide leader. However, since the export of Sfp1 was not prevented by deletion of sipF, the possibility of other enzymes with signal peptidase activity (most likely the S. suis housekeeping signal peptidase) compensating the function of SipF should be envisaged. This hypothetic alternative processing is, however, likely to hamper the efficient polymerization of the pilin subunits, as shown by the fact that the intensity of the higher molecular weight Sfp1-polymers was lower in the ΔsipF mutant than it was in the WT strain (Figure 2). Studies are currently being carried out in our laboratories to further understand the participation of SipF in the polymerization of Sfp1.
In this study, with the exception of the ΔsrtA mutant, we have not complemented the mutant strains with the WT genes that each is missing. However, since the mutants were generated by precise, in frame deletions that were verified by sequencing, we consider very unlikely the possibility of polar effects. In fact, inactivation of sipF and sfp2 (the more upstream genes of the srtF cluster) did not result in phenotypic changes, while eventual polar effects in the Δsfp1 mutant affecting also srtF expression, would have lead to a similar phenotype than that caused by disruption of sfp1 alone. Further, our results support new genome sequence data indicating that S. suis P1/7 sfp2 is a pseudogene , . Importantly, this genetic organization with a non functional sfp2 gene is shared by strains of S. suis serotype 2 belonging to the more virulent multilocus sequence typing ST1 complex , such as the recently sequenced Chinese isolates 98HAH12, 05ZYH33 and GZ1 , . In fact, in silico analysis suggests that sfp2 is also a pseudogene in these strains (data not shown). Furthermore, when we sequenced other well-characterized virulent S. suis serotype 2 strains (many of them belonging to the same ST1 complex), they presented the same ochre nonsense mutation in the sfp2 gene. Consistently, these strains did not produce the Sfp2 pilin subunit. Nevertheless, the possibility of some S. suis strains expressing pili formed by both Sfp1 and Sfp2 subunits cannot be excluded. In fact, it has recently been reported that a Spanish S. suis isolate may display Sfp2 on its surface . However, it is worth noting that Sfp2 was identified in that Spanish isolate by shaving the surface of bacteria with proteases followed by LC/MS/MS analysis of the resulting peptides and homology comparisons, and not by the use of mutagenesis and specific antibodies directed against that protein . Moreover, that study surprisingly suggested that Sfp2 might form the backbone of the pilus encoded by the srtF cluster of that isolate . However, that possibility is not supported by homology comparisons to the pili clusters of other Gram-positive bacteria , , , , nor is by data presented in the present study, which clearly show that Sfp1 constitutes the backbone of pili encoded by the srtF cluster.
We report here that pili encoded by the srtF pilus cluster of S. suis strain P1/7 are factors dispensable for adherence to porcine BMEC. They also are of minor importance for invasion of these cells. These results were not unexpected, since the srtF pilus lacks the pilin subunit Sfp2, which is, on the basis of homology comparisons, the putative pilin adhesin. To date, all described Gram-positive pili have at least one functional ancillary protein, and several groups of investigators have demonstrated that ancillary proteins play a major role in adhesion to host cells , , , . Indeed, deletion of the putative pilin adhesin in GBS resulted in a mutant strain expressing pili composed of the major subunit only, which showed impaired interactions with human BMEC . Moreover, other studies using streptococcal mutants reported that pili formed only by the major pilin subunit had diminished adhesive capacities compared to their respective parental strains , . In this regard, and despite our results for strain P1/7 and other strains analyzed in this study, it should be noted that we cannot rule out the possibility that the srtF cluster would contribute to adherence to and/or invasion of porcine BMEC if the putative adhesin Sfp2 were expressed, as it might plausibly be the case in other S. suis strains. In addition, although it is an unlikely hypothesis, since we have only tested interactions with porcine BMEC, we cannot exclude that pili formed only by Sfp1 might play a role in adhesion to other cell types.
The murine model used in this study has proven reliable and reproducible and constitutes an excellent alternative to the use of porcine models of infection , , , , , . However, this model uses the intraperitoneal route of inoculation  and, therefore, it overlooks the initial colonization of the upper respiratory tract by S. suis. Consequently, results of the murine trials presented here should be interpreted within these limitations. However, from our in vitro and in vivo results it may be advanced that pili encoded by the srtF cluster may not be critical for the full virulence of S. suis strain P 1/7. Indeed, the nonpiliated Δsfp1 mutant as well as the ΔsrtF mutant (which expresses Sfp1 monomers but not polymers in its surface) induced as strong sepsis in the mouse as did the WT strain. In addition, since no differences in the interactions with porcine BMEC were observed between the WT and the mutant strains, participation of pili in the first steps of S. suis meningitis might be unlikely. Interestingly, besides the srtF cluster, only two other putative pili clusters are found in strain P1/7 (Fig. S2) and none of them seem likely to be able to mediate pili formation . Indeed, the first of these additional clusters, designated as the srtE cluster, comprises a putative signal peptidase (SSU_0450) as well as the srtE gene (SSU_0453). However, this cluster lacks genes encoding the major and the ancillary pilin subunits. Instead, similar to the reported organization of the cluster in the S. suis serotype 2 reference strain , in strain P1/7 a putative exported protein (SSU_0451) and a transposase fragment (SSU_0452) are found between sipF and srtE [18 and unpublished data]. The remaining pilus cluster of strain P1/7 is homologous to the rlrA pilus island of S. pneumoniae TIGR4 . This cluster, named srtBCD cluster, contains three sortase-like genes (srtB, srtC, and srtD) and four other genes (designated sbp1, sbp2, sbp3, and sbp4), which putatively encode putative cell-wall anchor family proteins containing pilin motifs, E boxes and/or CWSSs . However, sbp2, which encodes the putative backbone subunit, is truncated by a nonsense mutation in strain P1/7 , leading to the notion that pili cannot be expressed from this cluster. Importantly, further analysis of a large collection of serotype 2 strains indicated that all tested strains of this serotype possessed an incomplete srtE cluster similar to that found in strain P1/7, and that they presented the same or other nonsense mutations in the sbp2 gene encoding the major subunit of the srtBCD cluster [18 and unpublished data]. Taken together with our in vivo evaluation in the mouse, these data suggest that pili in general might likely be dispensable for the full virulence of this highly virulent invasive isolate.
Several reports have shown that pili fulfill a myriad of virulence-related functions in different streptococcal pathogens , , . However, the notion of pili being essential for streptococcal virulence has not been systematically evaluated from an epidemiological perspective. To our knowledge, only a few studies have so far analyzed the correlation between production of pili and virulence using a large number of isolates recovered from the field , , . In a first study, the pilin-encoding gene rrgC (a member of the rlrA pilus cluster) was absent from 78% of 484 virulent S. pneumoniae strains tested . In addition, the presence of rrgC per se did not appear to be associated with increased virulence, since, when present, the gene was found at similar frequencies in nasopharyngeal and septicemic isolates . Similar results (rlrA pilus cluster present in only 27% of the virulent strains tested) were obtained when analyzing an essentially different pneumococcal collection of invasive isolates . Finally, a second S. pneumoniae pilus (PI-2) was found to be of low prevalence (16%) among clinical isolates . Taken together, these results suggest that despite published data obtained from mouse studies, pili might in fact not represent a central virulence factor for S. pneumoniae invasive disease in humans. These S. pneumoniae reports , ,  sustain therefore findings presented in the present study suggesting that pili may be not critical for the full virulence of some highly invasive S. suis isolates. It is to expect that future epidemiological studies carried out with S. suis and other streptococci will shed light on the actual contribution of pili to the virulence traits of pathogenic members of this important genus.
Materials and Methods
All animals used in this study were treated, and trials conducted, in accordance with the guidelines and policies of the Canadian Council on Animal Care (CCAC), enforced locally by the Ethics Committee of the Faculté de médecine vétérinaire of the Université de Montréal. The protocols and procedures were approved by the Ethics Committee.
Bacterial Strains, Plasmids, Media, Culture Conditions and Reagents
Bacterial strains and plasmids used in this study are listed in Table 1. Unless otherwise indicated, S. suis strains were grown in Todd-Hewitt (Becton Dickinson, Sparks, MD) broth (THB) or agar (THA) at 37°C. E. coli strains were grown in Luria-Bertani (LB) broth or agar (Becton Dickinson) at 37°C. When needed, antibiotics (Sigma, Oakville, ON, Canada) were added to the culture media at the following concentrations: for S. suis: spectinomycin (Sp) at 100 µg/ml; for E. coli: kanamycin (Km) and Sp at 50 µg/ml; chloramphenicol (Cm) at 30 µg/ml and ampicillin at 100 µg/ml. Unless otherwise indicated, all reagents used in this study were purchased from Sigma.
S. suis genomic DNA was prepared by the guanidium thiocyanathe method . Minipreparations of recombinant plasmids and transformation of E. coli were performed by standard procedures . Restriction enzymes and DNA-modifying enzymes were purchased from TaKaRa Bio (Otsu, Shiga, Japan) and used according to the manufacturers' directions. PCR reactions were carried out with the iProof proofreading DNA polymerase (BioRad Laboratories, Hercules, CA) or with Taq DNA polymerase (GE Healthcare, Piscataway, NJ). Oligonucleotide primers were from Invitrogen (Burlington, ON, Canada). Amplification products were purified on Sephadex S-400 columns (GE Healthcare) and sequenced with an ABI 310 automated DNA sequencer, using the ABI PRISM dye terminator cycle sequencing kit (Applied Biosystems, Foster City, CA).
Construction of Deletion Mutants
Precise, in-frame deletions in sipF, sfp2, sfp1 and srtF were constructed by using splicing-by-overlap-extension PCR . The primers used for the construction of deletion alleles are listed in Table S1. Appropriate deletion alleles generated by PCR were cloned into plasmid pCR2.1 (Invitrogen), extracted with BamHI and PstI and recloned into the thermosensitive E. coli-S. suis shuttle vector pSET4s  digested with the same enzymes. Plasmid pSAD11 used in this study for deletion of srtA was obtained by EcoT22I removal of the cat gene from plasmid pSAD1, previously used for insertional inactivation of srtA . Complementation of the ΔsrtA mutant was achieved by electroporation of the mutant with the previously described pSAcomp1 vector . This mutant was also mock-complemented with empty pSET-3 vector from which pSAcomp1 is derived , . Electroporation of S. suis and procedures for isolation of mutants were those described previously . Deletions of all genes were confirmed by PCR and sequencing analysis.
Expression and Purification of Recombinant 6xHis-Sfp1 and 6xHis-Sfp2 and Antibody Production
DNA fragments intragenic to sfp1 and sfp2 were generated by PCR using genomic DNA of S. suis strain P1/7 as template and the primer pairs Sfp1-fwd/Sfp1-rev (for sfp1) and Sfp2-fwd/Sfp2-rev and Sfp2-fwd2/Sfp2-rev2 (for sfp2), respectively (Table S1 and Figure 1). PCR amplicons were digested with NdeI and BamHI and cloned into plasmid pIVEX 2.4d (Roche Applied Science, Laval, QC, Canada), digested with the same enzymes. The resulting recombinant plasmids were introduced into E. coli TOP 10 (Invitrogen) for sequence analysis and storage and into E. coli BL21λDE3/pDIA17 for protein expression. Induction was carried out with IPTG, as previously described . Recombinant 6xHis-proteins were purified under denaturing conditions by affinity chromatography on Ni-NTA columns (Protino protein purification system, Macherey-Nagel, Düren, Germany) according to the manufacturers' recommendations. Protein purity was checked on SDS-PAGE and accurate protein concentrations were determined by a simplified Lowry test . Rabbit polyclonal antibodies (pAb) against the individual proteins were produced as previously described . The specificity of each antibody was determined by Western blotting against the purified 6xHis-proteins as well as against crude S. suis cell extracts prepared from the WT and mutant strains.
Cell Wall, Whole Cell and Culture Supernatant Protein Preparations
S. suis strains were grown in 10 ml of THB at 37°C. Bacteria were harvested by centrifugation during the late exponential phase of culture and resuspended in 220 µl spheroplasting buffer [10 ml spheroplasting buffer: 24 mg Tris, 20 mg MgCl26H2O, 2.6 g raffinose, 5000 U mutanolysin, one capsule Complete Mini EDTA-free protease inhibitor cocktail (Roche)], as described . The digestion was performed for 1 h at 37°C under gentle agitation. After centrifugation at 13,000×g for 15 min at 4°C, supernatants corresponding to the cell wall fractions were analyzed on SDS-PAGE. Total proteins extracts were prepared as previously described . Supernatants obtained after centrifugation of ON S. suis cultures grown in THB were concentrated 10-fold by Ultrafree-MC centrifugal filter devices (Millipore Corp., Bedford MA, USA).
Immunogold Electron Microscopy
S. suis WT and mutant strains were grown overnight at 37°C in 10 ml of THB, harvested by centrifugation, and resuspended in 250 µl of 1% glutaraldehyde in phosphate-buffered saline (PBS), pH 7.3. After fixation for 30 min, 20 µl of the bacterial suspensions were placed on nickel-Formvar grids (Canemco, Lakefield, QC, Canada) and allowed to partially air dry. Grids were subsequently blocked for 30 min with 10% normal donkey serum (Jackson ImmunoResearch) in dilution buffer (PBS containing 1% bovine serum albumin and 1% Tween-20, pH 7.3). Thereafter, samples were soaked in 50 µl of anti-Sfp1 or anti-Sfp2 specific pAb or control rabbit normal serum diluted 1/10 in dilution buffer for 2 h. The grids were then washed 5 times with dilution buffer, soaked in 50 µl of 10 nm colloidal gold-goat anti-rabbit IgG (Sigma) diluted 1/20 in dilution buffer, and incubated for 1 h. After three washes with PBS, grids were stained with 2% uranyl acetate for 30 s, and observed with a JEM-1230 electron microscope (JEOL Ltd, Tokyo, Japan) at an accelerating voltage of 80 kV.
Adherence to and Invasion of Porcine BMEC
The porcine BMEC cell line PBMEC/C1-2  was grown in Primaria 24-well tissue culture plates (Becton Dickinson, Franklin Lakes, NJ) using IF culture medium (a mixture of 1∶1 Iscove's modified Dulbecco's and Ham's F-12 media, Invitrogen) supplemented as previously described . S. suis strains were grown in THB for 16 h at 37°C, harvested by centrifugation, washed twice in PBS, and resuspended in fresh IF culture medium. The invasion assays were performed as described previously . Briefly, confluent monolayers of porcine BMEC at 105 cells/well were infected with 1-ml aliquots of bacterial suspensions at 105 CFU/ml (multiplicity of infection of 1). The plates were centrifuged at 800×g for 10 min and incubated for 2 h at 37°C under 5% CO2. The monolayers were then washed twice with PBS, 1 ml of cell culture medium containing 100 µg/ml of gentamicin and 5 µg/ml of penicillin G was added to each well, and incubation continued for 1 h. After incubation, monolayers were washed three times with PBS, trypsinized and disrupted by repeated pipetting. Serial dilutions of the cell lysates were plated onto THA and incubated overnight at 37°C. Invasion rates were calculated as the number of bacteria remaining after the antibiotic treatment with respect to the total number of inoculated bacteria. Adherence assays were performed essentially as described for invasion, but no antibiotic treatment was performed. After incubation for 2 h, cells were washed five times with PBS, trypsinized, disrupted, and serial dilutions of the cell lysates were plated as described above. Adherence rates were calculated as the number of bacteria remaining attached to cells after the incubation period with respect to the total number of inoculated bacteria.
Experimental Infection of Mice
A validated CD1 murine model of S. suis infection was used . In a first experiment, 50 female, 6-week old CD1 mice (Charles River Laboratories, Wilmington, MA) were divided in 5 groups of 10 animals (day 0). Group 1 was inoculated by intraperitoneal injection of 1 ml of S. suis strain P1/7 suspension at 5×107 CFU/ml, while groups 2, 3, 4 and 5 received the same dose of mutant strains ΔsipF, Δsfp2, Δsfp1 and ΔsrtF, respectively. Mice were monitored 3 times/day for 3 days for clinical signs and assigned clinical scores as previously described . Blood samples (5 µl) were collected daily from the tail vein and at necropsy by cardiac puncture and used to evaluate bacterial load by plating onto sheep blood agar plates. Isolated tiny α-hemolytic colonies were counted and assigned to S. suis by serotyping as previously described . At necropsy, macroscopic examination was performed. Bacterial colonization of the liver, spleen and brain of infected animals was also evaluated. Briefly, small pieces of these organs weighing 0.5 g were trimmed, placed in 500 µl of PBS and homogenized. Thereafter, 50 µl of the suspensions were plated as described above. A second experiment was carried out essentially as described above but the mice received a lower dose (1 ml of 1×107 CFU/ml) of S. suis P1/7 or mutant strains. In this second experiment, the WT and ΔsipF groups comprised 11 mice each while the other 3 groups (Δsfp2, Δsfp1 and ΔsrtF) were of 10 mice each. Animals were monitored as described above for 4 days.
PCR amplification of the srtF cluster in different S. suis serotype 2 strains using specific primers annealing upstream of sipF and downstream of srtF. All strains were positive for an 8.34 kb fragment, with the exception of North American strain 89–1591, which had been found not to produce Sfp1 monomers. Lane 1: Strain P1/7. Lane 2: Strain 31533. Lane 3: Strain 166. Lane 4: Strain D24. Lane 5: Strain S735 (serotype 2 reference strain). Lane 6: Strain D282. Lane 7: Strain LEF95. Lane 8: Strain HUD Limoges. Lane 9: Strain 89–1591. Lane 10, no DNA template.
(0.57 MB PDF)
Pilus clusters found in the genome of strain.
(0.30 MB PDF)
(0.05 MB DOC)
We are indebted to J.M. Betton (Institut Pasteur, France) and P. Friedl (Institut für Biochemie, Technische Hochschule Darmstadt, Germany) for kindly providing plasmid pDIA17 and the porcine BMEC/C1-2 cell line, respectively. We thank G. Vanier and S. Lacouture for useful suggestions and M. Grand'Maison and M. Takahashi for assistance.
Conceived and designed the experiments: NF DT MG. Performed the experiments: NF MdlCDP MPL DM. Analyzed the data: NF DT MO TS MG. Contributed reagents/materials/analysis tools: DT MO TS. Wrote the paper: NF MG.
- 1. Higgins R, Gottschalk M (2006) Streptococcocal Diseases. In: Straw BE, Zimmerman JJ, D'Allaire S, Taylor DJ, editors. Diseases of swine. Ames, Iowa: Blackwell Publishing Professional. pp. 769–783.
- 2. Gottschalk M, Segura M, Xu J (2007) Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim Health Res Rev 8: 29–45.
- 3. Mai NT, Hoa NT, Nga TV, Linh LD, Chau TT, et al. (2008) Streptococcus suis Meningitis in Adults in Vietnam. Clin Infect Dis 46: 659–667.
- 4. Suankratay C, Intalapaporn P, Nunthapisud P, Arunyingmongkol K, Wilde H (2004) Streptococcus suis meningitis in Thailand. Southeast Asian J Trop Med Public Health 35: 868–876.
- 5. Yu H, Jing H, Chen Z, Zheng H, Zhu X, et al. (2006) Human Streptococcus suis outbreak, Sichuan, China. Emerg Infect Dis 12: 914–920.
- 6. Smith HE, Damman M, van der Velde J, Wagenaar F, Wisselink HJ, et al. (1999) Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect Immun 67: 1750–1756.
- 7. Fittipaldi N, Sekizaki T, Takamatsu D, Dominguez-Punaro Mde L, Harel J, et al. (2008) Significant contribution of the pgdA gene to the virulence of Streptococcus suis. Mol Microbiol 70: 1120–1135.
- 8. Fittipaldi N, Sekizaki T, Takamatsu D, Harel J, Dominguez-Punaro Mde L, et al. (2008) D-alanylation of lipoteichoic acid contributes to the virulence of Streptococcus suis. Infect Immun 76: 3587–3594.
- 9. Baums CG, Kaim U, Fulde M, Ramachandran G, Goethe R, et al. (2006) Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis. Infect Immun 74: 6154–6162.
- 10. Vanier G, Segura M, Friedl P, Lacouture S, Gottschalk M (2004) Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2. Infect Immun 72: 1441–1449.
- 11. Dominguez-Punaro MC, Segura M, Plante MM, Lacouture S, Rivest S, et al. (2007) Streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection. J Immunol 179: 1842–1854.
- 12. Tenenbaum T, Papandreou T, Gellrich D, Friedrichs U, Seibt A, et al. (2009) Polar bacterial invasion and translocation of Streptococcus suis across the blood-cerebrospinal fluid barrier in vitro. Cell Microbiol 11: 323–336.
- 13. Fittipaldi N, Gottschalk M, Vanier G, Daigle F, Harel J (2007) Use of selective capture of transcribed sequences to identify genes preferentially expressed by Streptococcus suis upon interaction with porcine brain microvascular endothelial cells. Appl Environ Microbiol 73: 4359–4364.
- 14. Holden MT, Hauser H, Sanders M, Ngo TH, Cherevach I, et al. (2009) Rapid evolution of virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suis. PLoS ONE 4: e6072.
- 15. Dramsi S, Trieu-Cuot P, Bierne H (2005) Sorting sortases: a nomenclature proposal for the various sortases of Gram-positive bacteria. Res Microbiol 156: 289–297.
- 16. Mandlik A, Swierczynski A, Das A, Ton-That H (2008) Pili in Gram-positive bacteria: assembly, involvement in colonization and biofilm development. Trends Microbiol 16: 33–40.
- 17. Telford JL, Barocchi MA, Margarit I, Rappuoli R, Grandi G (2006) Pili in gram-positive pathogens. Nat Rev Microbiol 4: 509–519.
- 18. Takamatsu D, Nishino H, Ishiji T, Ishii J, Osaki M, et al. (2009) Genetic organization and preferential distribution of putative pilus gene clusters in Streptococcus suis. Vet Microbiol 138: 132–139.
- 19. Manetti AG, Zingaretti C, Falugi F, Capo S, Bombaci M, et al. (2007) Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol Microbiol 64: 968–983.
- 20. Nallapareddy SR, Singh KV, Sillanpaa J, Garsin DA, Hook M, et al. (2006) Endocarditis and biofilm-associated pili of Enterococcus faecalis. J Clin Invest 116: 2799–2807.
- 21. Konto-Ghiorghi Y, Mairey E, Mallet A, Dumenil G, Caliot E, et al. (2009) Dual role for pilus in adherence to epithelial cells and biofilm formation in Streptococcus agalactiae. PLoS Pathog 5: e1000422.
- 22. Bagnoli F, Moschioni M, Donati C, Dimitrovska V, Ferlenghi I, et al. (2008) A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells. J Bacteriol 190: 5480–5492.
- 23. Nelson AL, Ries J, Bagnoli F, Dahlberg S, Falker S, et al. (2007) RrgA is a pilus-associated adhesin in Streptococcus pneumoniae. Mol Microbiol 66: 329–340.
- 24. Rosch JW, Mann B, Thornton J, Sublett J, Tuomanen E (2008) Convergence of regulatory networks on the pilus locus of Streptococcus pneumoniae. Infect Immun 76: 3187–3196.
- 25. Maisey HC, Quach D, Hensler ME, Liu GY, Gallo RL, et al. (2008) A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB J 22: 1715–1724.
- 26. Mora M, Bensi G, Capo S, Falugi F, Zingaretti C, et al. (2005) Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens. Proc Natl Acad Sci U S A 102: 15641–15646.
- 27. Dramsi S, Caliot E, Bonne I, Guadagnini S, Prevost MC, et al. (2006) Assembly and role of pili in group B streptococci. Mol Microbiol 60: 1401–1413.
- 28. Maisey HC, Hensler M, Nizet V, Doran KS (2007) Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J Bacteriol 189: 1464–1467.
- 29. Nobbs AH, Rosini R, Rinaudo CD, Maione D, Grandi G, et al. (2008) Sortase A utilizes an ancillary protein anchor for efficient cell wall anchoring of pili in Streptococcus agalactiae. Infect Immun 76: 3550–3560.
- 30. Jacques M, Gottschalk M, Foiry B, Higgins R (1990) Ultrastructural study of surface components of Streptococcus suis. J Bacteriol 172: 2833–2838.
- 31. Proft T, Baker EN (2009) Pili in Gram-negative and Gram-positive bacteria - structure, assembly and their role in disease. Cell Mol Life Sci 66: 613–635.
- 32. Budzik JM, Marraffini LA, Schneewind O (2007) Assembly of pili on the surface of Bacillus cereus vegetative cells. Mol Microbiol 66: 495–510.
- 33. Zahner D, Scott JR (2008) SipA Is Required for Pilus Formation in Streptococcus pyogenes Serotype M3. J Bacteriol 190: 527–535.
- 34. Nakata M, Koller T, Moritz K, Ribardo D, Jonas L, et al. (2009) Mode of expression and functional characterization of FCT-3 pilus region-encoded proteins in Streptococcus pyogenes serotype M49. Infect Immun 77: 32–44.
- 35. King SJ, Leigh JA, Heath PJ, Luque I, Tarradas C, et al. (2002) Development of a multilocus sequence typing scheme for the pig pathogen Streptococcus suis: identification of virulent clones and potential capsular serotype exchange. J Clin Microbiol 40: 3671–3680.
- 36. Chen C, Tang J, Dong W, Wang C, Feng Y, et al. (2007) A Glimpse of Streptococcal Toxic Shock Syndrome from Comparative Genomics of S. suis 2 Chinese Isolates. PLoS ONE 2: e315.
- 37. Ye C, Zheng H, Zhang J, Jing H, Wang L, et al. (2008) Clinical, Experimental, and Genomic Differences between Intermediately Pathogenic, Highly Pathogenic, and Epidemic Streptococcus suis. J Infect Dis.
- 38. Rodriguez-Ortega MJ, Luque I, Tarradas C, Barcena JA (2008) Overcoming function annotation errors in the Gram-positive pathogen Streptococcus suis by a proteomics-driven approach. BMC Genomics 9: 588.
- 39. Scott JR, Zahner D (2006) Pili with strong attachments: Gram-positive bacteria do it differently. Mol Microbiol 62: 320–330.
- 40. Dominguez-Punaro Mde L, Segura M, Radzioch D, Rivest S, Gottschalk M (2008) Comparison of the susceptibilities of C57BL/6 and A/J mouse strains to Streptococcus suis serotype 2 infection. Infect Immun 76: 3901–3910.
- 41. Vanier G, Fittipaldi N, Slater JD, Dominguez-Punaro Mde L, Rycroft AN, et al. (2009) New putative virulence factors of Streptococcus suis involved in invasion of porcine brain microvascular endothelial cells. Microb Pathog 46: 13–20.
- 42. Vanier G, Sekizaki T, Dominguez-Punaro MC, Esgleas M, Osaki M, et al. (2008) Disruption of srtA gene in Streptococcus suis results in decreased interactions with endothelial cells and extracellular matrix proteins. Vet Microbiol 127: 417–424.
- 43. Osaki M, Takamatsu D, Shimoji Y, Sekizaki T (2002) Characterization of Streptococcus suis genes encoding proteins homologous to sortase of gram-positive bacteria. J Bacteriol 184: 971–982.
- 44. Basset A, Trzcinski K, Hermos C, O'Brien KL, Reid R, et al. (2007) Association of the Pneumococcal Pilus with Certain Capsular Serotypes but Not with Increased Virulence. J Clin Microbiol 45: 1684–1689.
- 45. Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M (2008) The presence of the pilus locus is a clonal property among pneumococcal invasive isolates. BMC Microbiol 8: 41.
- 46. Pitcher DG, Saunders NA, Owen RJ (1989) Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett Appl Microbiol 8: 151–156.
- 47. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning, a laboratory manual. New York: Cold Spring Harbor Laboratory Press.
- 48. Warrens AN, Jones MD, Lechler RI (1997) Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene 186: 29–35.
- 49. Takamatsu D, Osaki M, Sekizaki T (2001) Thermosensitive suicide vectors for gene replacement in Streptococcus suis. Plasmid 46: 140–148.
- 50. Takamatsu D, Osaki M, Sekizaki T (2001) Construction and characterization of Streptococcus suis-Escherichia coli shuttle cloning vectors. Plasmid 45: 101–113.
- 51. Roge J, Betton JM (2005) Use of pIVEX plasmids for protein overproduction in Escherichia coli. Microb Cell Fact 4: 18.
- 52. Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83: 346–356.
- 53. Li Y, Martinez G, Gottschalk M, Lacouture S, Willson P, et al. (2006) Identification of a surface protein of Streptococcus suis and evaluation of its immunogenic and protective capacity in pigs. Infect Immun 74: 305–312.
- 54. McNab R, Jenkinson HF (1998) Lipoproteins and other cell-surface associated proteins in streptococci. Methods in Cell Science 20: 209–216.
- 55. Vecht U, Wisselink HJ, Jellema ML, Smith HE (1991) Identification of two proteins associated with virulence of Streptococcus suis type 2. Infect Immun 59: 3156–3162.
- 56. Teifel M, Friedl P (1996) Establishment of the permanent microvascular endothelial cell line PBMEC/C1-2 from porcine brains. Exp Cell Res 228: 50–57.
- 57. Higgins R, Gottschalk M (1990) An update on Streptococcus suis identification. J Vet Diagn Invest 2: 249–252.
- 58. Slater JD, Allen AG, May JP, Bolitho S, Lindsay H, et al. (2003) Mutagenesis of Streptococcus equi and Streptococcus suis by transposon Tn917. Vet Microbiol 93: 197–206.
- 59. Berthelot-Herault F, Gottschalk M, Morvan H, Kobisch M (2005) Dilemma of virulence of Streptococcus suis: Canadian isolate 89–1591 characterized as a virulent strain using a standardized experimental model in pigs. Can J Vet Res 69: 236–240.
- 60. Vecht U, Arends JP, van der Molen EJ, van Leengoed LA (1989) Differences in virulence between two strains of Streptococcus suis type II after experimentally induced infection of newborn germ-free pigs. Am J Vet Res 50: 1037–1043.
- 61. de Moor CE (1963) Septicaemic Infections in Pigs, Caused by Haemolytic Streptococci of New Lancefield Groups Designated R, S and T. Antonie van Leewenhoek 29: 272–280.
- 62. Vecht U, Wisselink HJ, van Dijk JE, Smith HE (1992) Virulence of Streptococcus suis type 2 strains in newborn germfree pigs depends on phenotype. Infect Immun 60: 550–556.
- 63. Segura M, Vadeboncoeur N, Gottschalk M (2002) CD14-dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2. Clin Exp Immunol 127: 243–254.
- 64. Francois B, Gissot V, Ploy MC, Vignon P (1998) Recurrent septic shock due to Streptococcus suis. J Clin Microbiol 36: 2395.
- 65. Quessy S, Dubreuil JD, Caya M, Higgins R (1995) Discrimination of virulent and avirulent Streptococcus suis capsular type 2 isolates from different geographical origins. Infect Immun 63: 1975–1979.
- 66. Munier H, Gilles AM, Glaser P, Krin E, Danchin A, et al. (1991) Isolation and characterization of catalytic and calmodulin-binding domains of Bordetella pertussis adenylate cyclase. Eur J Biochem 196: 469–474.
- 67. Li Y, Gottschalk M, Esgleas M, Lacouture S, Dubreuil JD, et al. (2007) Immunization with recombinant Sao protein confers protection against Streptococcus suis infection. Clin Vaccine Immunol 14: 937–943.
- 68. Smith HE, Reek FH, Vecht U, Gielkens AL, Smits MA (1993) Repeats in an extracellular protein of weakly pathogenic strains of Streptococcus suis type 2 are absent in pathogenic strains. Infect Immun 61: 3318–3326.